Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

for
Neoplasms, Neoplasm Metastasis,
Location: Houston TX
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT05176665

Phase 1, Phase 2, Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Boston MA, New York NY, Fairfax VA, Miami FL,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase 1, Phase 2, Recruiting

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

for
Cervical Cancer, Throat Cancer, Oropharynx Cancer, Anal Cancer,
Location: New Brunswick NJ, Bethesda MD
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05686226

Phase 2, Recruiting

Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")

for
Stage III Solid Tumors, Stage IV Solid Tumors
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Sex: All

Age: 18+

Code: NCT05692466

Recruiting

Psychological Benefits of a Normalized Camping Experience for Children With Cancer

for
Pediatric Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 7 - 25

Code: NCT00001186

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Feasibility/Acceptability of Attentional-Control Training in Survivors

for
Pediatric Cancer, Pediatric ALL, Pediatric Brain Tumor,
Location: Washington DC
Sponsor: Children's National Research Institute

Sex: All

Age: 8 - 16

Code: NCT05528939

Recruiting

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

for
Malignant Brain Neoplasm, Malignant Solid Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT06788886

Recruiting

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06302621

Phase 1, Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Morristown NJ, Jacksonville FL, Chicago IL,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Salt Lake City UT,
Sponsor: Peel Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05329103

Phase 1, Recruiting

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

for
Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm,
Location: Houston TX
Sponsor: Lucid Lane, Inc

Sex: All

Age: 18+

Code: NCT04963972

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Houston TX, Beverly Hills CA, Santa Monica CA
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase 1, Recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: Cleveland OH
Sponsor: Biocity Biopharmaceutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT06548672

Phase 1, Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: Boston MA, Montreal, Durham NC, Toronto, Atlanta GA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Phase 4, Recruiting

3DUS Imaging of Needles in Gynecological Brachytherapy

for
Gynecologic Cancer
Location: London
Sponsor: Western University, Canada

Sex: Female

Age: 18+

Code: NCT04705467

Recruiting

Testicular Tissue Cryopreservation for Fertility Preservation

for
Cancer, Autoimmune Disorders
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT02972801

Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase 3, Recruiting

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

for
Prostate Cancer,
Location: New York NY, Philadelphia PA
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00503646

Recruiting

Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

for
Endometrial Hyperplasia, Endometrial Cancer, Gynecologic Cancer
Location: Vancouver
Sponsor: Vancouver Coastal Health Research Institute

Sex: Female

Age: 19 - 39

Code: NCT04362046

Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Atlanta GA, Louisville KY, Fairway KS, Dallas TX,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial